Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →32
🟠 Elevated
🤖 ML Fraud Detection Score: 98%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,700
Total Claims
$2.1M
Drug Cost
1,126
Beneficiaries
$1,889
Cost/Patient
Risk Score Breakdown 32/100
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-63%
Cost per patient vs peers
$1,889 vs $5,138 avg
-77%
Brand preference vs peers
13.8% vs 61.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.8%
Opioid Rate
795
Opioid Claims
$40K
Opioid Cost
7.9%
Long-Acting Rate
Brand vs Generic
Brand: 2,853 claims · $1.8M
Generic: 17,755 claims · $344K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 338 | $284K |
| Fluticasone/Umeclidin/Vilanter | 298 | $262K |
| Nintedanib Esylate | 14 | $177K |
| Budesonide/Glycopyr/Formoterol | 160 | $132K |
| Budesonide/Formoterol Fumarate | 128 | $69K |
| Fluticasone/Vilanterol | 109 | $69K |
| Rivaroxaban | 56 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 78 | $49K |
| Umeclidinium Brm/Vilanterol Tr | 54 | $43K |
| Sitagliptin Phosphate | 28 | $36K |
| Semaglutide | 31 | $36K |
| Ipratropium Bromide | 19 | $35K |
| Ipratropium/Albuterol Sulfate | 37 | $34K |
| Dulaglutide | 16 | $33K |
| Mirabegron | 44 | $32K |
Prescribing Profile
Patient Profile
75
Avg Age
53%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About